| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/14/2003 | US6506344 Multi-cell rotor |
| 01/14/2003 | US6506296 Micro-fuel cell sensor apparatus and method for modeling the sensor response time |
| 01/14/2003 | US6506168 Apparatus and method for obtaining blood for diagnostic tests |
| 01/14/2003 | US6506167 Blood-collecting tubes |
| 01/14/2003 | US6505524 Mixing system and method |
| 01/14/2003 | US6505523 Combustible gas measurement apparatus and method |
| 01/14/2003 | US6505498 Apparatus for determining a representative spring constant of a golf club head |
| 01/14/2003 | CA2339922C Device and method for non-invasively measuring and determining moisture content and density of loose and packaged tobacco |
| 01/14/2003 | CA2187356C Method and apparatus for testing soil contamination |
| 01/14/2003 | CA2140903C Biosensor for hematocrit determination |
| 01/14/2003 | CA2134582C Gas detecting method and apparatus |
| 01/14/2003 | CA2117118C Device for the direct measurement of low density lipoprotein cholesterol |
| 01/14/2003 | CA2086922C Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/13/2003 | CA2393376A1 Assay methods |
| 01/12/2003 | CA2390761A1 Sheet feeding mechanism |
| 01/09/2003 | WO2003003162A2 Evaluating neuropsychiatric diseases using a specimen-linked database |
| 01/09/2003 | WO2003003063A2 Fiber-optic sensor array |
| 01/09/2003 | WO2003003020A1 Method of detecting cancer and cancer detectors to be used therein |
| 01/09/2003 | WO2003003018A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/09/2003 | WO2003003017A2 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases |
| 01/09/2003 | WO2003003016A1 Diagnostic methods and agents |
| 01/09/2003 | WO2003003015A2 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 01/09/2003 | WO2003003014A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | WO2003003013A1 Non-nuclear effects of thyroid hormone |
| 01/09/2003 | WO2003003012A1 Identification of interacting molecules |
| 01/09/2003 | WO2003003011A1 Modification of angiogenesis by targeting protein tyrosine phosphatases |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003003007A2 Methods and compositions useful for the prediction of blood-brain barrier permeation |
| 01/09/2003 | WO2003003006A2 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | WO2003003005A2 Method and circuitry for controlling and measuring electrical parameters in a biological membrane |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |
| 01/09/2003 | WO2003002999A1 Method and detection of presence of hydrogen gas and measurement of content of hydrogen gas |
| 01/09/2003 | WO2003002979A2 Multiplex decoding of array sensors with microspheres |
| 01/09/2003 | WO2003002978A2 Directed enzymatic modification of analytes for affinity capture and analysis |
| 01/09/2003 | WO2003002977A1 Specimen-linked g protein coupled receptor database |
| 01/09/2003 | WO2003002976A2 Methods and reagents for detecting endotoxin |
| 01/09/2003 | WO2003002975A2 Biophotonic sensors and methods of use thereof |
| 01/09/2003 | WO2003002974A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 01/09/2003 | WO2003002765A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/09/2003 | WO2003002764A2 Screening method for identifying cancer therapy-relevant compounds |
| 01/09/2003 | WO2003002763A1 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 01/09/2003 | WO2003002757A1 Method for kidney disease detection by protein profiling |
| 01/09/2003 | WO2003002756A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 01/09/2003 | WO2003002755A2 Glaucoma treatments with reduced hyperpigmentation |
| 01/09/2003 | WO2003002753A2 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | WO2003002750A2 High throughput assay system |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002748A2 Detection of microbiological contaminants in samples of non-living material |
| 01/09/2003 | WO2003002742A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002724A2 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002721A2 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | WO2003002718A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 01/09/2003 | WO2003002716A2 Polymer stabilized proteinases |
| 01/09/2003 | WO2003002709A2 Novel technology for genetic mapping |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002600A1 Use of soluble cytokeratine-1-fragments in diagnostics and therapy |
| 01/09/2003 | WO2003002528A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 01/09/2003 | WO2003002141A1 Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002134A1 Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents |
| 01/09/2003 | WO2003002108A2 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 01/09/2003 | WO2003002105A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | WO2003002068A2 Diagnosis and treatment of cancer |
| 01/09/2003 | WO2003001985A2 Method for detection of melanoma |
| 01/09/2003 | WO2003001976A2 A secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 01/09/2003 | WO2003001964A2 Measurement testing of blood specimens |
| 01/09/2003 | WO2003001891A2 Method and apparatus for computer modeling of an adaptive immune response |
| 01/09/2003 | WO2003001881A2 Cell-based high-throughput screening methods |
| 01/09/2003 | WO2003001876A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | WO2002093126A3 Method and apparatus for downhole fluid characterization using flxural mechanical resonators |
| 01/09/2003 | WO2002090975A3 Method and device for identifying volatile substances in solution |
| 01/09/2003 | WO2002090923A9 Methods for assembling protein microarrays |
| 01/09/2003 | WO2002089985A3 Container for an analysis chip |
| 01/09/2003 | WO2002088425A3 Determination of chloride corrosion threshold for metals embedded in cementitious material |
| 01/09/2003 | WO2002084300A3 Diagnosing sjogren's syndrome |
| 01/09/2003 | WO2002082040A3 A 'one-device' system for testing constituents in fluids |
| 01/09/2003 | WO2002079786A9 Method for identifying drugs for the treatment of type ii diabetes |
| 01/09/2003 | WO2002078617A3 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002071062A9 Diagnosis and treatment of inflammation and hyperactive immune conditions |
| 01/09/2003 | WO2002071051A3 Acoustic sample introduction for analysis and/or processing |
| 01/09/2003 | WO2002066987A3 Method for the determination of specific proteins and an application |
| 01/09/2003 | WO2002063014A3 Human tyrosine-specific protein phosphatase |
| 01/09/2003 | WO2002059558A3 Means and methods for treatment evaluation |
| 01/09/2003 | WO2002057738A3 Nitric oxide (no) detector |
| 01/09/2003 | WO2002053247A3 Technique for rapid prediction of long-term hydrophobic organic contaminant desorption rates |
| 01/09/2003 | WO2002046731A3 Rotating potentiometric electrode |
| 01/09/2003 | WO2002046399A3 Mutated class i major histocompatibility proteins and complexes |
| 01/09/2003 | WO2002044701A3 Heating device |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002041784A3 Allergy test chamber |
| 01/09/2003 | WO2002037112A3 Detection of ovarian cancer |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002031491A3 Apparatus and methods for affinity capture tandem mass spectrometry |